Company profile
Enliven Therapeutics, Inc. Insider Trading
ELVNEvery SEC Form 4 insider trading filing for Enliven Therapeutics, Inc. (ELVN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001672619
- Filings
- 241
- Insiders
- 23
- Last filing
- 2026-09-17
Activity summary
No discretionary insider buying or selling in the last 30 days. The 10 transactions filed were made under a 10b5-1 plan, scheduled in advance rather than decided on the day.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Enliven Therapeutics, Inc. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $52.9M.
90 day insight
Over the last 90 days, Enliven Therapeutics, Inc. insiders filed 41 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Helen Louise Collins with 16 transactions totaling $845K.
- Largest single sale: $9.6M by Mika K Derynck on Aug 4, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Helen Louise Collins | ELVN | Option Exercise10b5 | 5,000 | $2.48 | $12K |
| Sep 17, 2026 | Helen Louise Collins | ELVN | Sale10b5 | 2,916 | $50.03 | $146K |
| Sep 17, 2026 | Helen Louise Collins | ELVN | Sale10b5 | 1,844 | $50.71 | $94K |
| Sep 17, 2026 | Helen Louise Collins | ELVN | Sale10b5 | 240 | $51.48 | $12K |
| Sep 17, 2026 | Helen Louise Collins | ELVN | Option Exercise10b5 | 5,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ELVN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Enliven Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →